Factor Vii Deficiency
📧 Sign up to get email alerts when something new happens for Factor Vii Deficiency.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency) [Phase 1]
Phase 1 clinical trial evaluating SR604 for safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy participants and in pati…
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: Study Comparing the Pharmacokinetic of Biosimilar Eptacog Alfa With Novoseven®, in Patients With Congenital Factor VII Deficiency [Phase 3]
A Phase 3 trial comparing pharmacokinetics of a biosimilar Eptacog Alfa with NovoSeven in patients with congenital Factor VII deficiency has…
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: Observational Study on Safety and Efficacy of NovoSeven® in Subjects With Congenital FVII Deficiency
This completed observational study evaluates the safety and efficacy of NovoSeven (recombinant activated factor VII) in individuals with con…
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: Treatment of Inherited Factor VII Deficiency
This update notes that a clinical trial studying treatment for inherited Factor VII deficiency has completed.